Treatment News : Gut Bacteria May Cause Inflammation, Aggravate HIV Disease

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2013

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 26, 2013

Gut Bacteria May Cause Inflammation, Aggravate HIV Disease

Bacteria in the intestines of people living with HIV may perpetuate the body’s initial inflammatory immune response to the virus and account for various chronic diseases, which are disproportionate among the population even in the face of successful antiretroviral (ARV) treatment, according to findings published in Science Translational Medicine and reported by the San Francisco Business Times. Investigators studied the microbes living within seven HIV-positive participants not taking ARVs, 18 people with an undetectable viral load thanks to successful treatment and nine HIV-negative participants who were matched to the others in terms of similar health risks.

The researchers found that the population of microbes in the HIV-positive participants stood in stark contrast to that of their HIV-negative counterparts. Those living with HIV had more gut bacteria that can cause damaging inflammation, including Pseudomonas, Salmonella, E. coli and Staphylococcus.

There was a correlation between a disruption in the normal bacterial population of the human gut and levels of an inflammatory molecule in the blood known as IL-6, as well as to an enzyme by the name of indoleamine 2,3-dioxygenase. This enzyme can inhibit the gut’s role as a barrier, opening the gates for bacteria and other molecules to enter the body and cause more harmful inflammation. Furthermore, the researchers found higher levels in the HIV-positive participants of certain species of bacteria that are able to mimic this enzyme.

To read the San Francisco Business Times story, click here.

To read the study abstract, click here.

To read the release on the study, click here.

Search: Gut, intestines, microbiome, microbes, Science Translational Medicine, San Francisco Business Times, Pseudomonas, Salmonella, E. coli, Staphylococcus, indoleamine 2, 3-dioxygenase, IL-6, enzyme, inflammation.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.